L 12 Pill - yellow round
Pill with imprint L 12 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Lannett Company, Inc.
Letrozole is used in the treatment of Breast Cancer, Adjuvant; Breast Cancer, Metastatic; Breast Cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for L 12
Letrozole
- Imprint
- L 12
- Strength
- 2.5 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Aromatase inhibitors, Hormones/antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Lannett Company, Inc.
- National Drug Code (NDC)
- 00527-1712
- Inactive Ingredients
-
mannitol,
microcrystalline cellulose,
lactose monohydrate,
sodium starch glycolate type A potato,
magnesium stearate,
polyvinyl alcohol,
polyethylene glycol 3350,
titanium dioxide,
magnesium silicate,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "L 12"
More about letrozole
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (351)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: aromatase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.